Quantification of neurotrophin mRNA expression in PMN mouse: Modulation by xaliproden

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 2, 2004, Pages 157-163

  Appert Collin, A ^a   Duong, F H T ^a   Passilly Degrace, P ^a   Gies, J P ^a   Warter J M ^a   Poindron, Philippe ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Neurotrophins; PMN mouse; RT PCR; SR57746A; Trk receptors

Indexed keywords

NEUROTROPHIN; NEUROTROPHIN RECEPTOR; XALIPRODEN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOWN REGULATION; DRUG EFFECT; GENE; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LIFESPAN; MOTOR NEURON DISEASE; MOUSE; MOUSE STRAIN; NERVE DEGENERATION; NEUROTROPHIN GENE; NEUROTROPISM; NGF GENE; NONHUMAN; NT 3 GENE; PRIORITY JOURNAL; QUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRK GENE;

EID: 8344224009     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700207     Document Type: Article

References (34)

1. Sagot Y., R. Vejsada and A.C. Kato. 1997. Clinical and molecular aspects of motoneuron diseases: animal models, neurotrophic factors and Bcl-2 oncoprotein. Trends Pliarmacol. 18:330.
2. Johnson D., A. Lanahan, C.R. Buck, A. Sehgal, C. Morgan, E. Mercer, M. Bothwell and M.V. Chao. 1986. Expression and structure of the human NGF receptor. Cell 47:545.
3. Battleman D.S., A.I. Geller and M.V. Chao. 1993. HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75 hNGFR defines high-affinity NGF binding. J. Neurosci. 13:941.
4. Chao M.V. 1992. Neurotrophin receptors: a window into neuronal differentiation. Neuron 9:583.
5. Hempstead B.L., N. Patil, B. Theil and M.V. Chao. 1990. Deletion of cytoplasmic sequences of the NGF receptor leads to loss of high affinity ligand binding. J. Biol. Chem. 265:9595.
6. Hempstead B.L., D. Martin-Zanca, D.R. Kaplan, L.F. Parada and M.V. Chao. 1991. High affinity NGF binding requires coexpression on the trk proto-oncogene and the low affinity NGF receptor. Nature 350:678.
7. Meakin S.O. and E.M. Shooter. 1991. Molecular investigations on the high affinity nerve growth factor receptor. Neuron 6:153.
8. Cordon-Cardo C., P. Tapley, S. Jing, V. Nanduri, E. O'Rourke, F. Lamballe, et al. 1991. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell 66:173.
9. Glass D.J., S.H. Nye, P. Hantzopoulos, MJ. Macchi, et al. 1991. TrkB mediates BDNF/NT-3 dependant survival and proliferation in fibroblasts lacking the low affinity NGF receptor. Cell 66:405.
10. Hempstead B.L., SJ. Rabin, L. Kaplan, et al. 1992. Over-expression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation. Neuron 9:883.
11. Kaplan D.R., D. Martin-Zanca and L.F. Parada. 1991. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 350:158.
12. Klein R., S. Jing, V. Nanduri, E. O'Rourke and M. Barbacid. 1991. The trk proto-oncogen encodes a receptor for nerve growth factor. Cell 65:189.
13. Klein R., V. Nanduri, S. Jing, et al. 1991. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 66:395.
14. Lamballe F., R.J. Smeyne and M. Barbacid. 1994. Developmental expression of trkC, the neurotrophin-3 receptor, in the mammalian nervous system. J. Neurosci. 14:14.
15. Lindsay R.M., S.J. Wiegand, C.A. Anthony and P.S. Distefano. 1994. Neurotrophic factors: from molecule to man. Trends Neurosci. 6:182.
16. Soppet D., E. Escandon, J. Maragos, et al. 1992. The neurotrophic factors brain derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 65:895.
17. Squinto S.P., T.N. Stitt, T.H. Aldrich, et al. 1991. TrkB encodes a functional receptor for brain derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65:885.
18. Ip N.Y., T.N. Stitt, R. Tapley, et al. 1993. Similarities and differences in the way neurotrophins interact with the trk receptors in neuronal and nonneuronal cells. Neuron 10:137.
19. Fournier J., P.E. Keane, P. Ferrara and P. Soubrie. 1997. SR57746A: an orally active non-peptide compound with neuroprotective effects. CNS Drug Reviews 3:148.
20. Duong F., J. Fournier, P.E. Keane, et al. 1998. The effect of the non-peptide compound SR57746A on the progression of the disease state of the PMN mouse. Br. J. Pharmacol. 124:811.
21. Schmalbruch H., H.J.S. Jensen, M. Bjaerg, Z. Kamieniecka and L. A. Kurland. 1991. New mouse mutant with progressive motor neuronopathy. J. Neuropathol. Exp. Neurol. 50:192.
22. Kennel P.F., P. Fonteneau, E. Martin, et al. 1996. Electromyographical and motor performance studies in the PMN mouse model of neurodegenerative disease. Neurobiol. Dis. 3:137.
23. Duong H.T.F., P.E. Keane, J.M. Warter, P. Poindron and P. Passilly. 1999. Effect of the non-peptide neurotrophic compound SR57746A on the phenotypic survival of mouse purified motoneuron. Br. J. Pharmacol. 128:1385.
24. Brunialti A.L., C. Poirier, H. Schmalbruch and J.L. Guenet. 1995. The mouse mutation progressive motor neuronopathy (PMN) maps to chromosome 13. Genomics 29:131.
25. Fournier J., R. Steinberg, T. Gauthier, et al. 1993. Protective effects of SR57746A in central and peripheral models of neurodegenerative disorders in rodents and primates. Neuroscience 55:629.
26. Labie C., C. Lafon, J. Fournier, et al. 1998. Effect of the non-peptide neuroprotective compound SR57746A on NGF and BDNF synthesis in primary astrocytes in culture. Br. J. Pharmacol. 123:80P.
27. Griesbeck O., A. Parsadanian, M. Sendtner and H. Thoenen. 1995. Expression of neurtrophins in skeletal muscle: quantitative comparison and significance for motoneuron survival and maintenance of function. J. Neurosci. Res. 42:21.
28. Weis C., J. Marksteiner and C. Kumpel. 2001. Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert. Neuroscience 102:129.
29. Sagot Y., T. Rosse, R. Vejsada, D. Perrelet and A.C. Kato. 1998. Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease. J. Neurosci. 18:1132.
30. Haase G., P. Kennel, B. Pettman, et al. 1997. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat. Med. 3:429.
31. Terenghi G. 1999. Peripheral nerve regeneration and neurotrophic factors. J Anat. 194:1.
32. Sendtner M., B. Holtmann and R.A. Hughes. 1996. The response of motoneurons to neurotrophins. Neurochem. Res. 21:831.
33. Martin N., J. Jaubert, P. Gounon, et al. 2002. A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nature Genetics 32:443.
34. Fernyhough P. and D.N. Ishii. 1987. Nerve growth factor modulates tubulin transcript levels in pheochromocytoma PC12 cells. Neurochem. Res. 12:891.